As per our new research report “ Global Contract Manufacturing Market Analysis”, the Indian pharmaceutical sector has registered an outstanding growth during the last few years and has become the hub of pharmaceutical companies owing to low cost manufacturing, large population, and high demand. As per our research, the contract manufacturing market is quite mature with around over 100 manufacturing facilities in the country that are approved by the US regulator.
India’s reputation as a premier destination for outsourcing of pharma manufacturing work is evident from the trust endowed by big MNC companies in the domestic players. For instance, nearly 20 months after Pfizer signed a licensing and supply agreement with Aurobindo Pharmaceuticals for 80 products, the two companies recently signed another agreement for around 40 products. The agreement worth around US$ 70 Million would boost the overall revenue of Aurobindo to a great extent. Backed by the above stated factors, the contract manufacturing market in India is expected to grow at a CAGR of over 45% during 2011-2013.
Besides, we have done thorough research and prudent analysis of the global contract manufacturing market and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that, rising cost pressure on pharmaceutical companies, soaring demand for pharmaceuticals worldwide, and rising private investments will provide the much required impetus to the industry. The current decision taken by the governments of the US, Germany, France, the UK, and Spain will create a pressure on the global pharmaceutical majors to reduce their costs. Thus, these firms will look for the contract manufacturing facilities in the emerging countries.
“Global Contract Manufacturing Market Analysis”, provides an extensive research and prudent analysis of the global contract manufacturing industry. It gives an insight into the current and future market trends. The report has also studied the key contract manufacturers in all the countries to help clients understand the overall market dynamics. The report will work as an investment guide for the clients looking to invest or outsource their manufacturing in these markets.
For more information visit: http://www.rncos.com/Report/IM265.htm |
